| Price | 0.195p on 01-04-2026 at 15:05:17 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.20p |
| Sell | 0.19p |
| Last Trade: | Sell 87,933.00 at 0.1935p |
| Day's Volume: | 505,072 |
| Last Close: | 0.195p |
| Open: | 0.195p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.195p - 0.195p |
| 52wk Range: | 0.18p - 0.286p |
| Market Capitalisation: | £4.19m |
| VWAP: | 0.196735p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 87,933 | 0.1935p | Ordinary |
15:28:35 - 01-Apr-26 |
| Sell* | 40,000 | 0.1935p | Ordinary |
11:48:24 - 01-Apr-26 |
| Sell* | 6,000 | 0.195p | Ordinary |
11:37:09 - 01-Apr-26 |
| Buy* | 250,000 | 0.20p | Ordinary |
11:17:04 - 01-Apr-26 |
| Sell* | 121,139 | 0.1935p | Ordinary |
08:28:19 - 01-Apr-26 |
| Buy* | 245,497 | 0.1998p | Ordinary |
12:27:31 - 31-Mar-26 |
| Sell* | 4,342 | 0.1931p | Ordinary |
10:29:38 - 31-Mar-26 |
| Buy* | 5,000 | 0.20p | Ordinary |
08:36:25 - 31-Mar-26 |
| Buy* | 2,547,121 | 0.1963p | Ordinary |
13:35:47 - 30-Mar-26 |
| Sell* | 43,625 | 0.1931p | Ordinary |
11:39:56 - 30-Mar-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
